Fluvoxamine vs Placebo and Time to Recovery in Outpatients With Mild to Moderate COVID-19-Reply

Matthew W McCarthy¹, Christopher J Lindsell^{2

3}, Susanna Naggie⁴

Affiliations

¹ Weill Cornell Medicine, New York, New York.
² Vanderbilt University Medical Center, Nashville, Tennessee.
³ Now with the Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, North Carolina.
⁴ Duke Clinical Research Institute, Durham, North Carolina.

Comment

Matthew W McCarthy et al. JAMA. 2023.

. 2023 May 16;329(19):1702-1703.

doi: 10.1001/jama.2023.5064.

Matthew W McCarthy¹, Christopher J Lindsell^{2

3}, Susanna Naggie⁴

¹ Weill Cornell Medicine, New York, New York.
² Vanderbilt University Medical Center, Nashville, Tennessee.
³ Now with the Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, North Carolina.
⁴ Duke Clinical Research Institute, Durham, North Carolina.

No abstract available

Comment on

Fluvoxamine vs Placebo and Time to Recovery in Outpatients With Mild to Moderate COVID-19.
Ashraf S, Ashraf N. Ashraf S, et al. JAMA. 2023 May 16;329(19):1702. doi: 10.1001/jama.2023.5061. JAMA. 2023. PMID: 37191708 No abstract available.